Table 2.
The results of response to chemotherapy, the number of total patients was 152.
| Response / Type of regimen, N (%) | ECF (n = 32) | DCF (n = 51) | FOLFOX (n = 37) | FLOT (n = 32) | P-value |
|---|---|---|---|---|---|
| Response rate | |||||
| PRa | 18 (56.3%) | 36 (70.6%) | 27 (73.0%) | 26 (81.3%) | |
| CRb | 0 (0%) | 3 (5.9%) | 1 (2.7%) | 1 (3.1%) | |
| SDc | 10 (31.3%) | 7 (13.7%) | 6 (16.2%) | 4 (12.5%) | 0.002 |
| PDd | 4 (12.4%) | 5 (9.8%) | 3 (8.1%) | 1 (3.1%) | |
| Overall response ratee | 18 (56.3%) | 39 (76.4%) | 28 (75.7%) | 27 (84.37%) | < 0.001 |
| Disease control ratef | 22 (87.6%) | 46 (90.2%) | 34 (91.9%) | 34 (96.8%) | < 0.001 |
| Resection rate | |||||
| R0g | 24 (75.0%) | 48 (94.1%) | 30 (81.8%) | 30 (93.8%) | |
| R1h | 8 (25.0%) | 3 (5.9%) | 7 (18.9%) | 2 (6.2%) | 0.03 |
| Hospitalization rate | 12 (37.5%) | 26 (45.6%) | 6 (16.2%) | 13 (37.25) | 0.05 |
a Partial response, b complete response, c stable disease, d progression disease, e partial response + complete response; f partial response + complete response + stable disease; g no microscopic cancer cell residual in the primary tumor site;h microscopic cancer cell residual in the primary tumor site.